Olympus Corporation (OCPNF)

Market Cap	16.92B
Revenue (ttm)	6.80B
Net Income (ttm)	525.24M
Shares Out	n/a
EPS (ttm)	0.45
PE Ratio	32.22
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	15.50
Previous Close	15.63
Day's Range	15.50 - 15.50
52-Week Range	12.39 - 17.65
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 14, 2025

About Olympus

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 28,838
• Stock Exchange: OTCMKTS
• Ticker Symbol: OCPNF

Financial Performance

In 2023, Olympus's revenue was 936.21 billion, an increase of 6.16% compared to the previous year's 881.92 billion. Earnings were 242.57 billion, an increase of 69.12%.

Financial numbers in JPY